Skip to main content
SCI Pharmtech, Inc. logo

SCI Pharmtech, Inc. — Investor Relations & Filings

Ticker · 4119 ISIN · TW0004119003 TW Manufacturing
Open in API
Filings indexed 1,696 across all filing types
Latest filing 2026-04-29 Report Publication Anno…
Country TW Taiwan
Listing TW 4119

About SCI Pharmtech, Inc.

https://www.sci-pharmtech.com.tw

SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.

Recent filings

Filing Released Lang Actions
公告本公司115年第一季財務合併報告董事會預計召開 日期為115年5月7日。
Report Publication Announcement Classification · 85% confidence The document is a short announcement indicating the board meeting schedule to approve the company’s Q1 consolidated financial report. It does not contain the actual interim financial statements but merely notifies the timing of report publication/approval. According to the “menu vs meal” rule, this is a report publication announcement, matching the RPA category.
2026-04-29 Chinese
113年8月變更登記
Share Issue/Capital Change Classification · 90% confidence The document is an official disclosure from the Public Information Observatory (Taiwan MOPS) providing detailed share capital data: par value per share, approved capital, paid-in capital, and breakdown of capital sources and changes. This aligns with a Share Issue/Capital Change filing, as it reports on the company’s capital structure and any changes thereto.
2026-04-21 Chinese
公司基本資料
Regulatory Filings Classification · 82% confidence The document is a standard corporate information disclosure from a public company information platform (‘公開資訊觀測站’) showing basic corporate data (stock code, industry, address, directors, capital, auditor, etc.). It is neither an AGM material, financial report, earnings release, nor a capital or legal announcement. It does not fit any specific specialized category, so it falls under the general regulatory filings fallback category (RNS).
2026-04-21 Chinese
115年年報及股東會資料 — 2026_4119_20260522F13.pdf
Regulatory Filings
2026-04-17 Chinese
115年年報及股東會資料 — 2026_4119_20260522F17.pdf
Regulatory Filings
2026-04-17 Chinese
115年年報及股東會資料 — 2026_4119_20260522F02.pdf
Regulatory Filings
2026-04-17 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.